Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding.

@article{Sung2011EarlyCE,
  title={Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding.},
  author={Joseph J. Y. Sung and Derek Luo and Justin Che-Yuen Wu and Jessica Yuet-Ling Ching and Francis Chan and James Y W Lau and Susanne Mack and Robin Ducharme and Patrick T. Okolo and Marcia Canto and Anthony N. Kalloo and Samuel A. Giday},
  journal={Endoscopy},
  year={2011},
  volume={43 4},
  pages={291-5}
}
BACKGROUND AND STUDY AIMS Endoscopic therapy of upper gastrointestinal bleeding remains challenging with conventional endoscopic devices. Use of Hemospray, where a nanopowder with clotting abilities is sprayed onto the bleeding site, had been highly effective for management of arterial bleeding in a heparizined animal model. The safety and effectiveness of Hemospray for hemostasis of active peptic ulcer bleeding in humans was evaluated. PATIENTS AND METHODS In a prospective, single-arm, pilot… CONTINUE READING